Vanguard Group Inc Rhythm Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,447,911 shares of RYTM stock, worth $205 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,447,911

Previous 3,360,695 2.6%

Holding current value

$205 Million

Previous $138 Million 30.91%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$40.81 - $55.0 $3.56 Million - $4.8 Million	87,216 Added 2.6%	3,447,911 $181 Million
Q2 2024 Aug 13, 2024	BUY	$35.41 - $44.37 $2 Million - $2.51 Million	56,549 Added 1.71%	3,360,695 $138 Million
Q1 2024 May 10, 2024	BUY	$39.12 - $52.44 $3.02 Million - $4.05 Million	77,208 Added 2.39%	3,304,146 $143 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $4.54 Million - $10.5 Million	212,370 Added 7.04%	3,226,938 $148 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $1.35 Million - $2.37 Million	85,139 Added 2.91%	3,014,568 $69.1 Million
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $4.59 Million - $5.95 Million	281,293 Added 10.62%	2,929,429 $48.3 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $874,755 - $1.77 Million	51,822 Added 2.0%	2,648,136 $47.2 Million
Q4 2022 Feb 10, 2023	BUY	$22.21 - $30.25 $8.04 Million - $11 Million	362,042 Added 16.2%	2,596,314 $75.6 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $363,547 - $2.61 Million	84,546 Added 3.93%	2,234,272 $54.7 Million
Q2 2022 Aug 12, 2022	SELL	$3.12 - $12.25 $334,757 - $1.31 Million	-107,294 Reduced 4.75%	2,149,726 $8.92 Million
Q1 2022 May 13, 2022	SELL	$6.13 - $12.24 $407,651 - $813,972	-66,501 Reduced 2.86%	2,257,020 $26 Million
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $90,018 - $145,157	10,443 Added 0.45%	2,323,521 $23.2 Million
Q3 2021 Nov 12, 2021	BUY	$11.68 - $20.72 $650,062 - $1.15 Million	55,656 Added 2.47%	2,313,078 $30.2 Million
Q2 2021 Aug 13, 2021	BUY	$18.52 - $22.55 $41.8 Million - $50.9 Million	2,257,422 New	2,257,422 $44.2 Million

Others Institutions Holding RYTM

# of Institutions

188

Shares Held

67.1M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.31B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Rhythm Pharmaceuticals, Inc. Transaction History